CKPT - What's Going On With Checkpoint Therapeutics (CKPT) Stock Nosediving? | Benzinga
Checkpoint Therapeutics Inc (NASDAQ: CKPT) shares are trading lower by 52.7% to $1.57 Monday morning after the company received a complete response letter (CRL) from the FDA regarding their application for cosibelimab, a treatment for certain types of skin cancer.
The letter pointed ...
CKPT) Stock Nosediving?>Full story available on Benzinga.com